Venture Insider
Subscribe
Sign in
Home
Notes
Archive
About
The GLP-1 Second Wave — Weight Loss 2.0 Is Already Here, And It’s Oral
Three years ago, if you told a room full of Wall Street analysts that a diabetes drug would become the world’s best-selling pharmaceutical — bigger than…
2 hrs ago
•
Venture Insider
The Most Valuable Company in History Won’t Let You Buy a Single Share
I want to tell you about a company that just filed to go public at a valuation that would make it the largest IPO in the history of financial markets.
Mar 7
•
Venture Insider
4
The hidden investment opportunity inside Europe's $800 billion rearmament
Six months ago, a fund manager based in Paris called me to talk about his defense exposure.
Mar 4
•
Venture Insider
Why I’m Betting on Water — Not Chips — to Capitalize on the AI Bubble
Last week, I asked ChatGPT 47 questions to draft an investment memo.
Mar 3
•
Venture Insider
Venture Insider
Venture Insider dissects how companies really work — their business models, incentives, and strategic decisions — before the market fully understands them.
Subscribe
Venture Insider
Subscribe
About
Archive
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
